Chemokines

Recombinant Human TARC (CCL17)

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 300-30
Description:
Recombinant Human TARC (CCL17)

TARC, a CC chemokine, is predominantly produced by dendritic cells in the thymus, and signals through the CCR4 receptor. TARC is chemotactic towards T cells. Recombinant Human TARC is an 8.0 kDa protein containing 71 amino acid residues, including the four conserved cysteine residues present in CC chemokines.

Source: E.coli

Synonyms: Thymus and Activation Regulated Chemokine, CCL17, ABCD-2

AA Sequence: ARGTNVGREC CLEYFKGAIP LRKLKTWYQT SEDCSRDAIV FVTVQGRAIC SDPNNKRVKN AVKYLQSLER S

Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to chemoattract human T cells using a concentration range of 1.0-10.0 ng/ml.

Calculated Molecular Weight: 8 kDa

Accession Number: Q92583

Gene ID: 6361

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

First Author
Ocaña-Guzmán, R
Title
Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity.
Citation
Journal Of Immunology Research; 2021 pg6654220
PubMed Id
First Author
Yasuoka, H
Title
Increased both PD-L1 and PD-L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
Citation
Scientific Reports; 10(1) pg10377
PubMed Id
First Author
Anderson, C A
Title
A degradatory fate for CCR4 suggests a primary role in Th2 inflammation.
Citation
Journal of Leukocyte Biology; 107(3) pg455-466
PubMed Id